Selection of Human Single Domain Antibodies (sdAb) Against Thymidine Kinase 1 and Their Incorporation Into sdAb-Fc Antibody Constructs For Potential Use In Cancer Therapy
Edwin J. Velazquez, Jordan D. Cress, Tyler B. Humpherys, Toni O. Mortimer, David M. Bellini, Jonathan R Skidmore, Kathryn R. Smith, Richard A. Robison, Scott K. Weber, Kim L. O’Neill
doi: https://doi.org/10.1101/2021.05.04.21256554
Edwin J. Velazquez
1Department of Microbiology and Molecular Biology, Brigham Young University, Provo, UT, USA
Jordan D. Cress
1Department of Microbiology and Molecular Biology, Brigham Young University, Provo, UT, USA
Tyler B. Humpherys
1Department of Microbiology and Molecular Biology, Brigham Young University, Provo, UT, USA
Toni O. Mortimer
1Department of Microbiology and Molecular Biology, Brigham Young University, Provo, UT, USA
David M. Bellini
1Department of Microbiology and Molecular Biology, Brigham Young University, Provo, UT, USA
Jonathan R Skidmore
1Department of Microbiology and Molecular Biology, Brigham Young University, Provo, UT, USA
Kathryn R. Smith
1Department of Microbiology and Molecular Biology, Brigham Young University, Provo, UT, USA
Richard A. Robison
1Department of Microbiology and Molecular Biology, Brigham Young University, Provo, UT, USA
Scott K. Weber
1Department of Microbiology and Molecular Biology, Brigham Young University, Provo, UT, USA
Kim L. O’Neill
1Department of Microbiology and Molecular Biology, Brigham Young University, Provo, UT, USA
Article usage
Posted May 07, 2021.
Selection of Human Single Domain Antibodies (sdAb) Against Thymidine Kinase 1 and Their Incorporation Into sdAb-Fc Antibody Constructs For Potential Use In Cancer Therapy
Edwin J. Velazquez, Jordan D. Cress, Tyler B. Humpherys, Toni O. Mortimer, David M. Bellini, Jonathan R Skidmore, Kathryn R. Smith, Richard A. Robison, Scott K. Weber, Kim L. O’Neill
medRxiv 2021.05.04.21256554; doi: https://doi.org/10.1101/2021.05.04.21256554
Selection of Human Single Domain Antibodies (sdAb) Against Thymidine Kinase 1 and Their Incorporation Into sdAb-Fc Antibody Constructs For Potential Use In Cancer Therapy
Edwin J. Velazquez, Jordan D. Cress, Tyler B. Humpherys, Toni O. Mortimer, David M. Bellini, Jonathan R Skidmore, Kathryn R. Smith, Richard A. Robison, Scott K. Weber, Kim L. O’Neill
medRxiv 2021.05.04.21256554; doi: https://doi.org/10.1101/2021.05.04.21256554
Subject Area
Subject Areas
- Addiction Medicine (405)
- Allergy and Immunology (714)
- Anesthesia (209)
- Cardiovascular Medicine (2986)
- Dermatology (254)
- Emergency Medicine (446)
- Epidemiology (12847)
- Forensic Medicine (12)
- Gastroenterology (839)
- Genetic and Genomic Medicine (4652)
- Geriatric Medicine (428)
- Health Economics (735)
- Health Informatics (2960)
- Health Policy (1076)
- Hematology (394)
- HIV/AIDS (938)
- Medical Education (430)
- Medical Ethics (116)
- Nephrology (478)
- Neurology (4441)
- Nursing (239)
- Nutrition (653)
- Oncology (2310)
- Ophthalmology (655)
- Orthopedics (260)
- Otolaryngology (328)
- Pain Medicine (285)
- Palliative Medicine (85)
- Pathology (504)
- Pediatrics (1205)
- Primary Care Research (506)
- Public and Global Health (7039)
- Radiology and Imaging (1557)
- Respiratory Medicine (927)
- Rheumatology (447)
- Sports Medicine (387)
- Surgery (494)
- Toxicology (60)
- Transplantation (213)
- Urology (186)